BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29325236)

  • 21. Olanzapine-induced weight gain in anorexia nervosa: involvement of leptin and ghrelin secretion?
    Brambilla F; Monteleone P; Maj M
    Psychoneuroendocrinology; 2007 May; 32(4):402-6. PubMed ID: 17395395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic potential of ghrelin in restricting-type anorexia nervosa.
    Hotta M; Ohwada R; Akamizu T; Shibasaki T; Kangawa K
    Methods Enzymol; 2012; 514():381-98. PubMed ID: 22975066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Olanzapine Versus Placebo in Adult Outpatients With Anorexia Nervosa: A Randomized Clinical Trial.
    Attia E; Steinglass JE; Walsh BT; Wang Y; Wu P; Schreyer C; Wildes J; Yilmaz Z; Guarda AS; Kaplan AS; Marcus MD
    Am J Psychiatry; 2019 Jun; 176(6):449-456. PubMed ID: 30654643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-Term Effects of Relamorelin on Descending Colon Motility in Chronic Constipation: A Randomized, Controlled Trial.
    Acosta A; Camilleri M; Busciglio I; Boldingh A; Nelson AD; Burton D
    Dig Dis Sci; 2016 Mar; 61(3):852-60. PubMed ID: 26467700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of gender on the acute effects of whey protein ingestion on energy intake, appetite, gastric emptying and gut hormone responses in healthy young adults.
    Giezenaar C; Luscombe-Marsh ND; Hutchison AT; Lange K; Hausken T; Jones KL; Horowitz M; Chapman I; Soenen S
    Nutr Diabetes; 2018 Jul; 8(1):40. PubMed ID: 30006513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association Between Ghrelin and Body Weight Trajectory in Individuals With Anorexia Nervosa.
    Kim YR; Lauze MS; Slattery M; Perlis RH; Holsen LM; Breithaupt L; Stern CM; Fava M; Thomas JJ; Lawson EA; Misra M; Eddy KT
    JAMA Netw Open; 2023 Mar; 6(3):e234625. PubMed ID: 36961462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ghrelin stimulates gastric emptying and hunger in normal-weight humans.
    Levin F; Edholm T; Schmidt PT; Grybäck P; Jacobsson H; Degerblad M; Höybye C; Holst JJ; Rehfeld JF; Hellström PM; Näslund E
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3296-302. PubMed ID: 16772353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ghrelin activation and neuropeptide Y elevation in response to medium chain triglyceride administration in anorexia nervosa patients.
    Kawai K; Nakashima M; Kojima M; Yamashita S; Takakura S; Shimizu M; Kubo C; Sudo N
    Clin Nutr ESPEN; 2017 Feb; 17():100-104. PubMed ID: 28361739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obesity does not increase effects of synthetic ghrelin on human gastric motor functions.
    Cremonini F; Camilleri M; Vazquez Roque M; McKinzie S; Burton D; Baxter K; Zinsmeister AR
    Gastroenterology; 2006 Nov; 131(5):1431-9. PubMed ID: 17101319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship of body weight with gastrointestinal motor and sensory function: studies in anorexia nervosa and obesity.
    Bluemel S; Menne D; Milos G; Goetze O; Fried M; Schwizer W; Fox M; Steingoetter A
    BMC Gastroenterol; 2017 Jan; 17(1):4. PubMed ID: 28056812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metoclopramide-induced gastric emptying in patients with anorexia nervosa.
    Saleh JW; Lebwohl P
    Am J Gastroenterol; 1980 Aug; 74(2):127-32. PubMed ID: 7446514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dronabinol in severe, enduring anorexia nervosa: a randomized controlled trial.
    Andries A; Frystyk J; Flyvbjerg A; Støving RK
    Int J Eat Disord; 2014 Jan; 47(1):18-23. PubMed ID: 24105610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oesophageal and gastric motility disorders in patients categorised as having primary anorexia nervosa.
    Stacher G; Kiss A; Wiesnagrotzki S; Bergmann H; Höbart J; Schneider C
    Gut; 1986 Oct; 27(10):1120-6. PubMed ID: 3781322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous ghrelin accelerates postoperative gastric emptying and time to first bowel movement in humans.
    Falkén Y; Webb DL; Abraham-Nordling M; Kressner U; Hellström PM; Näslund E
    Neurogastroenterol Motil; 2013 Jun; 25(6):474-80. PubMed ID: 23527561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous cisapride accelerates delayed gastric emptying and increases antral contraction amplitude in patients with primary anorexia nervosa.
    Stacher G; Bergmann H; Wiesnagrotzki S; Kiss A; Schneider C; Mittelbach G; Gaupmann G; Höbart J
    Gastroenterology; 1987 Apr; 92(4):1000-6. PubMed ID: 3556983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study.
    Murray CD; Martin NM; Patterson M; Taylor SA; Ghatei MA; Kamm MA; Johnston C; Bloom SR; Emmanuel AV
    Gut; 2005 Dec; 54(12):1693-8. PubMed ID: 16085693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial.
    Halawi H; Khemani D; Eckert D; O'Neill J; Kadouh H; Grothe K; Clark MM; Burton DD; Vella A; Acosta A; Zinsmeister AR; Camilleri M
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):890-899. PubMed ID: 28958851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state.
    Broglio F; Gianotti L; Destefanis S; Fassino S; Abbate Daga G; Mondelli V; Lanfranco F; Gottero C; Gauna C; Hofland L; Van der Lely AJ; Ghigo E
    Clin Endocrinol (Oxf); 2004 May; 60(5):592-9. PubMed ID: 15104562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastric antral injections of botulinum toxin delay gastric emptying but do not reduce body weight.
    Topazian M; Camilleri M; Enders FT; Clain JE; Gleeson FC; Levy MJ; Rajan E; Nehra V; Dierkhising RA; Collazo-Clavell ML; Talley NJ; Clark MM
    Clin Gastroenterol Hepatol; 2013 Feb; 11(2):145-50.e1. PubMed ID: 23063681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of camicinal (GSK962040), a motilin agonist, on gastric emptying and glucose absorption in feed-intolerant critically ill patients: a randomized, blinded, placebo-controlled, clinical trial.
    Chapman MJ; Deane AM; O'Connor SL; Nguyen NQ; Fraser RJ; Richards DB; Hacquoil KE; Vasist Johnson LS; Barton ME; Dukes GE
    Crit Care; 2016 Aug; 20(1):232. PubMed ID: 27476581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.